Druzak, Samuel
Iffrig, Elizabeth
Roberts, Blaine R. http://orcid.org/0000-0001-5466-0053
Zhang, Tiantian
Fibben, Kirby S.
Sakurai, Yumiko
Verkerke, Hans P.
Rostad, Christina A.
Chahroudi, Ann http://orcid.org/0000-0001-7479-9546
Schneider, Frank
Wong, Andrew Kam Ho
Roberts, Anne M.
Chandler, Joshua D. http://orcid.org/0000-0003-3211-7935
Kim, Susan O.
Mosunjac, Mario
Mosunjac, Marina
Geller, Rachel
Albizua, Igor
Stowell, Sean R.
Arthur, Connie M.
Anderson, Evan J. http://orcid.org/0000-0002-1576-4420
Ivanova, Anna A. http://orcid.org/0000-0002-6221-6240
Ahn, Jun
Liu, Xueyun
Maner-Smith, Kristal
Bowen, Thomas
Paiardini, Mirko http://orcid.org/0000-0002-7276-3600
Bosinger, Steve E. http://orcid.org/0000-0002-2116-5061
Roback, John D. http://orcid.org/0000-0001-9952-2252
Kulpa, Deanna A. http://orcid.org/0000-0002-0411-7295
Silvestri, Guido http://orcid.org/0000-0001-6602-2470
Lam, Wilbur A. http://orcid.org/0000-0002-0325-7990
Ortlund, Eric A. http://orcid.org/0000-0001-8855-3029
Maier, Cheryl L. http://orcid.org/0000-0003-4044-2674
Article History
Received: 29 October 2022
Accepted: 8 March 2023
First Online: 4 April 2023
Competing interests
: E.J.A. has consulted for Pfizer, Sanofi Pasteur, Janssen, and Medscape, and his institution receives funds to conduct clinical research unrelated to this manuscript from MedImmune, Regeneron, PaxVax, Pfizer, GSK, Merck, Sanofi-Pasteur, Janssen, and Micron. He also serves on a safety monitoring board for Kentucky BioProcessing, Inc. and Sanofi Pasteur. His institution has also received funding from NIH to conduct clinical trials of Moderna and Janssen COVID-19 vaccines. C.A.R.’s institution has received funds to conduct clinical research unrelated to this manuscript from BioFire Inc, GSK, MedImmune, Micron, Janssen, Merck, Novavax, PaxVax, Regeneron, and Sanofi-Pasteur. She is co-inventor of patented RSV vaccine technology unrelated to this manuscript, which has been licensed to Meissa Vaccines, Inc. Her institution has received funds from NIH, Moderna, Pfizer, and Janssen to conduct clinical trials of COVID-19 vaccines. B.R.R. receives research support from Agilent, Bruker and eMSion for projects unrelated to this manuscript. The remaining authors declare no competing interests.